- Home
- ZDAI vs ICCM Comparison
ZDAI vs ICCM Comparison
Compare ZDAI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZDAI | ICCM |
|---|---|---|
| Founded | 2022 | 2006 |
| Country | Hong Kong | Israel |
| Employees | 33 | N/A |
| Industry | General Bldg Contractors - Nonresidential Bldgs | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.4M | 41.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | ZDAI | ICCM |
|---|---|---|
| Price | $3.40 | $0.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 2.8K | ★ 746.3K |
| Earning Date | 05-15-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.28 |
| 52 Week High | $6.56 | $1.40 |
Technical Indicators
Market Signals| Indicator | ZDAI | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 53.49 | 36.62 |
| Support Level | $3.49 | $0.28 |
| Resistance Level | $4.10 | $0.74 |
| Average True Range (ATR) | 0.32 | 0.04 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 51.72 | 59.45 |
Price Performance
Historical ComparisonAbout ZDAI Primega Group Holdings Limited Ordinary Shares
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.